Cardiology
- DIR Index
- Basic and Pharmaceutical Sciences
- Clinical Specialties
- Athletes' Precautions and Banned Drugs
- Bioterrorism and Disaster Planning
- Cancer
- Cardiology
- Clinical Practice Guidelines
- CNS Disorders
- Dermatology
- Emergency Medicine
- Endocrine Disorders
- Gastroenterology
- Geriatric Patients
- Gynecology
- Health Technology Assessment
- Hepatic Disease and Hepatotoxicity
- Laboratory Medicine
- LGBTQ+ Resources
- Infectious Disease
- Natural Medicines
- Neonatology
- Nutrition
- Obesity
- Oncology
- Pain Management/Palliative Care
- Pediatric Patients
- Psychopharmacology
- Pregnant or Lactating Patients
- Renal Disease: Drug Dosing and Drug-Induced Nephrotoxicity
- Reproductive Health
- Respirology
- Substance Use/Substance Related Disorders
- Drug-Related Resources
- Evidence Based Resources
- Health Administration and Systems
- Pharmacy Learning and Teaching
- Pharmacy Practice
Websites
Alerting Services
- Cardiology Resource Centers (Medscape, registration required)
- Clinical Trial Results
- EvidenceAlerts (BMJ Group/McMaster Plus, register and choose specialty area)
- TheHeart.Org (Registration required)
Arryhthmias
- QTDrugs List (CredibleMeds, registration required)
Professional Organizations
- American College of Cardiology
- American College of Chest Physicians
- American Heart Association
- British Columbia Cardiovascular Guidelines
- Canadian Cardiovascular Society
- Canadian Hypertension Society
- European Society of Cardiology
- Heart and Stroke Foundation of Canada
- International Society of Hypertension
- National Heart, Lung and Blood Institute
Professional Organizations - Guidelines and Policy Statements
- Canadian Cardiovascular Society Guideline Programs
- Clinical Practice Guidelines (European Society of Cardiology)
- Clinical Practice Guidelines (National Heart Lung and Blood Institute)
- Practice Guidelines & Quality Standards (American College of Cardiology)
Trends and Risk Factors
Clinical Practice Guidelines for Specific Conditions
Arrhythmias
- Canadian Cardiovascular Society Consensus Conference: Atrial Fibrillation 2004 Executive Summary (PDF)
- ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death - Full Text
- Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.Europace. 2006 Sep;8(9):651-745.
- Blomstrom-Lundqvist C, Scheinman MM, Aliot EM et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias - executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 2003 Oct 15;42(8):1493-531. Review
Atrial Fibrillation
Canadian Guidelines:
- Canadian Cardiovascular Society: Guidelines for the Management of Atrial Fibrillation (2018)
- Canadian Cardiovascular Society: Guidelines for the Management of Atrial Fibrillation Focused Update (2018)
- Thombosis Canada: Stroke Prevention in Atrial Fibrillation (2017)
Other Guidelines:
Cardiology Practice Guidelines for Pharmacists
- Hypertension guidelines for pharmacists: 2009 update
- The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary (PUBMED)
- 2014 CHEP Recommendations (Canadian Hypertension Society)
- 2008 Canadian Hypertension Education Program Guidelines for the management of hypertension by pharmacists
- Guidelines for the management of dyslipidemia and prevention of cardiovascular disease by pharmacists
Congestive Heart Failure
Canadian Guidelines:
- Canadian Cardiovascular Society: The CCS Comprehensive Update of the Management of Heart Failure (2017)
- Canadian Cardiovascular Society: Heart Failure Companion (2016)
Other Guidelines:
- NICE Pathway: Acute Heart Failure (UK, 2019)
- NICE Pathway: Chronic Heart Failure (UK, 2019)
- NICE Guideline: Acute Heart Failure (UK, 2014)
- NICE Guideline: Chronic Heart Failure (UK, 2018)
- American Heart Association & American College of Cardiology: Management of Heart Failure (US, 2013)
Dyslipidemia & Lifestyle Modification
Canadian Guidelines:
Other Guidelines:
- NICE Pathway: Cardiovascular Disease Prevention (UK, 2019)
- NICE Guideline: Lipid modification (UK, 2016)
- American College of Cardiology: Guideline on the Management of Blood Cholesterol (US, 2018)
- American Heart Association & American College of Cardiology: Lifestyle Management to Reduce Cardiovascular Risk (US, 2013)
- J Genest, R McPherson, J Frohlich et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol 2009;25(10):567-579.
- McPherson R, Frohlich J, Fodor G et al. Canadian Cardiovascular Society position statement - recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.Can J Cardiol. 2006 Sep;22(11):913-27.
- Dyslipidemia in Adults with Diabetes (Canadian Diabetes Association Clinical Practice Guidelines Expert Committee)
- Genest et al. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: 2003 update. CMAJ 169 (9): 921.
- U.S. National Heart, Lung, and Blood Institute. National Cholesterol Education Program (NCEP). Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III)
- National Cholesterol Education Program
Heart Failure
- Canada
- Howlett JG, McKelvie RS, Costigan J for the Canadian Cardiovascular Society. The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. Can J Cardiol. 2010 Apr;26(4):185-202. Review.
- Howlett JG, McKelvie RS, Arnold JM et al for the Canadian Cardiovascular Society. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol. 2009 Feb;25(2):86-105.
- Malcom J, Arnold O, Howlett JG et al for the Canadian Cardiovascular Society. Canadian Cardiovascular Society Consensus Conference guidelines on heart failure - 2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies. Can J Cardiol. 2008 Jan;24(1):21-40.
- Arnold JM, Howlett JG, Dorian P et al. Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol. 2007 Jan;23(1):21-45.
- Europe
- United States
Hypertension
Canadian Guidelines:
Other Guidelines:
- NICE Pathway: Hypertension (UK, 2019)
- American Society of Hypertension: Management of High Blood Pressure in Adults (US, 2014)
- NICE Guideline: Hypertension in Adults: Diagnosis & Management (UK, 2019)
- 2011 Canadian Hypertension Education Program recommendations: An annual update. Can Fam Physician. 201 Dec;57(12):1393-1397.
- 2008 Canadian Hypertension Education Program Guidelines for the Management of Hypertension by Pharmacists
- The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I - Blood pressure measurement, diagnosis and assessment of risk.
- The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy
- Dietary approaches to Prevent and Treat Hypertension: A Scientific Statement from the American Heart Association
- NICE Guidance Documents: Hypertension - Management in Adults in Primary Care
Ischemic Heart Disease & Coronary Artery Disease
Acute Coronary Syndrome
Canadian Guidelines:
- Canadian Cardiovascular Society: The 2019 ACC/AHA Guidelines for the Acute Management of ST Elevation Myocardial Infarction: A Focused Update (2019)
Other Guidelines:
- NICE Pathway: Early Management of Unstable Angina and NSTEMI (UK, 2019)
- NICE Pathway: Myocardial Infarction with ST-segment Elevation (UK, 2018)
- American Heart Association & American College of Cardiology: Management of Patients With Non–ST-Elevation Acute Coronary Syndromes (US, 2014)
- NICE Guideline: Myocardial Infarction with ST-segment Elevation (UK, 2013)
- American Heart Association & American College of Cardiology: Management of ST-Elevation Myocardial Infarction (US, 2013)
- NICE Guideline: MI - Secondary Prevention (UK, 2013)
- NICE Guideline: Unstable Angina and NSTEMI (UK, 2013)
- ACC/AHA 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) (PDF)
- AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update.
- 2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina (PDF)
- Canadian Guidelines:
- Canadian Cardiovascular Society: The 2007 ACC/AHA Guidelines for the Management of ST Elevation Myocardial Infarction: A Perspective and Adaptation for Canada (2009)
Stable Angina Pectoris
Canadian Guidelines:
- Canadian Cardiovascular Society & Canadian Pain Society:Management of Patients With Refractory Angina (2012)
Other Guidelines:
Metabolic Syndrome
- Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009 Oct 20; 120(16):1640-5. Epub 2009 Oct 5.
- Graham I, Atar D, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies adn by invited experts). Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113.
- Graham I, Atar D, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:E1-40.
Peripheral Vascular Disease
Primary Prevention
- Redberg RF, Benjamin EJ, Bittner V et al. ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. J Am Coll Cardiol. 2009 Sep 29;54(14):1364-405. PubMed PMID: 19778679.
Secondary Prevention
- Becker RC, Meade TW, Berger PB et al. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).Chest. 2008 Jun;133(6 Suppl):776S-814S.
Venous Thromboembolism
Canadian Guidelines:
- Thrombosis Canada: Deep Vein Thombosis Treatment (2019)
- Thrombosis Canada: Deep Vein Thrombosis Diagnosis (2015)
- Thrombosis Canada: Heparin-Induced Thrombocytopenia (2015)
Other Guidelines:
- NICE Pathway: Venous Thromboembolism (UK, 2015)
- American Heart Association: Management of Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension (US, 2011)
- NICE Guideline: Venous Thromboembolism (UK, 2018)
Resources
Patient Decision Aids
- Patient Decision Aids (National Prescribing Centre)
- Patient Decision Aids (Ottawa Hospital Research Institute)
Patient Information
- Arrhythmias (MedLinePlus)
- Cardiomyopathy (MedLinePlus)
- Cholesterol Good and Bad (MedLinePlus)
Print and Electronic Resources
*Recommended texts & electronic resources are linked to publishers' or book sellers' websites for further ordering information
Cardiovascular Risk Management (Hobbs & Arroll, 2009) - $- Cardiovascular Therapeutics (Antman, Sabatine, 4th ed., 2013)
- Critical Pathways in Cardiovascular Medicine (Cannon & O'Gata, 2nd ed. 2006) - $
- Hurst's the Heart (Fuster et al. 14th ed. 2017) - $
- Kaplan's Clinical Hypertension (Kaplan & Victor, 11th ed. 2014) - $
- Management of Complex Cardiovascular Problems (Nguyen et al. 4th ed. 2016) - $
- Management Strategies in Antithrombotic Therapy (Askari et al. 2007) - $
- Pharmacotherapy: A Pathophysiologic Approach (DiPiro et al. 9th ed. 2014)
- PSAP-VI: Pharmacotherapy Self-Assessment Program: Cardiology (American College of Clinical Pharmacy) - $
- Textbook of Cardiovascular Medicine (Topol, 3rd ed. 2007) - $
- The APhA Complete Review for Pharmacy (Feeney, 11th ed. 2015) - $
- see Section 2: Cardiovascular Disorders - $
- see Chapter 12: Hypertension
- see Chapter 13: Heart Failure
- see Chapter 14: Cardiac Arrhythmias
- see Chapter 15: Ischemic Heart Disease and Acute Coronary Syndrome
- see Chapter 16: Dyslipidemia
- see Chapter 41: Thromboembolic Disease
Published: 01 Jun 2015
Revised: 21 Aug 2017